Wear a continuous glucose monitor with type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 to 80 years old
- You have type 2 diabetes and it has been present more than 6 months
- Your recent HbA1c is in the 45–70 mmol/mol range (a blood test for average glucose)
- You have a smartphone and have been checking your blood sugar yourself before starting
- You can read instructions and participate safely (no severe vision or major thinking/psych issues that prevent this)
- You are not using prandial (meal-time) insulin or pregnant/breastfeeding
- You do not have significant kidney problems (eGFR below 45) or current/active cancer concerns
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether using a continuous glucose monitor (CGM, a sensor that tracks blood sugar) is practical and helpful for people with type 2 diabetes in primary care settings. It focuses on people who may have a harder time getting diabetes support and have higher A1c levels.
This study gives continuous glucose monitors (CGMs) to people with type 2 diabetes who cannot afford them. It looks at whether using a CGM helps improve blood sugar control.
This trial compares two types of continuous glucose monitors to see which works better for people with type 2 diabetes who use insulin. You will wear a sensor that tracks your blood sugar levels continuously or at set times, and the study will help find the best way to manage your diabetes.
This real-world study tests whether using a continuous glucose monitor (isCGM) with or without pharmacist coaching helps people with type 2 diabetes who are not on insulin improve their blood sugar control. It compares these approaches to standard blood sugar checking and looks for better HbA1c results after three months.
This trial is testing whether using a continuous glucose monitor (CGM) for different lengths of time helps people with type 2 diabetes understand their blood sugar patterns. You won't need to change your current diabetes medications.
This trial tests whether using continuous glucose monitor (CGM) data can help doctors and patients better manage type 2 diabetes. It is for people who already use insulin and a CGM device to check their blood sugar levels.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.